Shorter Scans and Better Image Quality: Deep Learning-Based MR Image Reconstruction Tech From GE Healthcare Now FDA Cleared
May 27 2020 - 4:30PM
Business Wire
- AIR Recon DL is MR industry’s first 510(k)-cleared, deep
learning-based image reconstruction technology that works across
all anatomies
- With COVID-19 postponing up to 5,000,000 U.S. patients’ MR
scans* to date, AIR Recon DL can help providers process the backlog
faster without compromising image quality
GE Healthcare today announced U.S. FDA 510(k) clearance of AIR
Recon DL. This pioneering technology, using a deep learning-based
neural network, improves the patient experience through shorter
scan times while also increasing diagnostic confidence with better
image quality across all anatomies. AIR Recon DL, developed on GE
Healthcare’s Edison intelligence platform, seamlessly integrates
into the clinical workflow to generate AIR Recon DL images in
real-time at the operator’s console.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200527005903/en/
AIR Recon DL delivers shorter scans and
better image quality (Photo: Business Wire)
Until now, there was an inherent compromise in MR between image
quality and scan time. Better image quality achieved through higher
signal-to-noise (SNR) and/or spatial resolution needed to show
anatomical detail necessitated long scan times. Shorter scans,
aimed to improve patient comfort and productivity, compromised
image quality and diagnostic confidence. Now with AIR Recon DL,
clinicians and technologists will no longer have to choose between
image quality and scan time.
“In our experience, [AIR Recon DL] enables us to back off on the
number of [signal] averages or achieve a higher matrix, to either
save on scan time or achieve a higher resolution image,” said Dr.
Hollis Potter, chairman of the department of radiology and imaging
at Hospital for Special Surgery in New York City.
Unlike conventional post processing-based approaches that can
obscure image detail, AIR Recon DL is a deep learning-based
reconstruction engine making full use of raw data for maximum image
quality. In addition to improving SNR, this technology features a
unique intelligent ringing suppression that preserves fine image
details, helping address two common pain points for radiologists
and technologists—image noise and ringing.
AIR Recon DL was developed in partnership with global
institutions and has been evaluated on thousands of cases across a
wide range of anatomies and patient demographics. Feedback from
clinical users has been overwhelmingly positive, including users
noticing sharper and less noisy images enabling shorter scan times,
increased reader confidence, reducing the need for repeat scans,
and more scan-to-scan consistency.
“We are proud to bring the next generation of MR image
reconstruction to the industry leveraging the latest technological
revolution in artificial intelligence,” said Jie Xue, president and
CEO of GE Healthcare MR. “AIR Recon DL benefits clinicians,
technologists and patients alike. As we transition to a post-COVID
world, MR providers face a significant backlog of patient exams.
AIR Recon DL can not only help providers scan more patients per
day, but also allows more time to disinfect equipment between
patients.”
Partners in the development and clinical validation of AIR Recon
DL included Hospital for Special Surgery, University of California
San Francisco, RadNet, University of Wisconsin-Madison, MD Anderson
Cancer Center, Medical College of Wisconsin, Centre Cardiologique
du Nord in France, Erasmus Medical Center in the Netherlands,
Centro Cardiologico Monzino in Italy, University of Yamanashi and
Keio University in Japan, and Asan Medical Center and Haeundae Paik
Hospital in Korea.
AIR Recon DL was developed on GE Healthcare’s Edison
intelligence platform, which helps GE and strategic partners
design, develop, manage, secure and distribute advanced
applications and AI algorithms quickly.
AIR Recon DL is available as an upgrade or with new system
purchases. It is currently available on GE Healthcare’s 3.0T MR
systems.
*Based on 2019 IMV data and GE service data
About GE Healthcare:
GE Healthcare is the $16.7 billion healthcare business of GE
(NYSE: GE). As a leading global medical technology and digital
solutions innovator, GE Healthcare enables clinicians to make
faster, more informed decisions through intelligent devices, data
analytics, applications and services, supported by its Edison
intelligence platform. With over 100 years of healthcare industry
experience and around 50,000 employees globally, the company
operates at the center of an ecosystem working toward precision
health, digitizing healthcare, helping drive productivity and
improve outcomes for patients, providers, health systems and
researchers around the world. Follow us on Facebook, LinkedIn,
Twitter and Insights, or visit our website www.gehealthcare.com for
more information.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200527005903/en/
Amanda Gintoft Amanda.Gintoft@ge.com +1 414 412 7062
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Mar 2024 to Apr 2024
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Apr 2023 to Apr 2024